Login / Signup
Letter: the risk of gastrointestinal bleeding in patients taking third-generation P2Y12 inhibitors compared with clopidogrel.
Jian Zhao
Published in:
Alimentary pharmacology & therapeutics (2020)
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
acute coronary syndrome
prognostic factors
coronary artery disease
atrial fibrillation
patient reported